Log in

6620 Handa Pharmaceuticals Inc TPEX · Taiwan

Handa Pharmaceuticals (6620) news

Handa Pharmaceuticals Inc is a public biotech or pharmaceutical company listed on TPEX under the ticker 6620, recorded under Taiwan. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Handa Pharmaceuticals news

We have not published a story on Handa Pharmaceuticals yet. When there is news, it will appear here.

Questions about Handa Pharmaceuticals

What is the ticker symbol of Handa Pharmaceuticals?

Handa Pharmaceuticals Inc trades under the ticker 6620 on TPEX.

Where is Handa Pharmaceuticals listed?

Handa Pharmaceuticals Inc is listed on TPEX.

Which country or territory is Handa Pharmaceuticals listed under?

Our directory records Handa Pharmaceuticals Inc under Taiwan.

What does Handa Pharmaceuticals do?

Our directory classifies Handa Pharmaceuticals Inc as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Handa Pharmaceuticals?

The ISIN recorded for Handa Pharmaceuticals Inc is TW0006620008.

Does aibio.space cover Handa Pharmaceuticals?

aibio.space lists Handa Pharmaceuticals Inc among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Handa Pharmaceuticals?

Companies in our directory listed in the same country and business area as Handa Pharmaceuticals: Nang Kuang Pharmaceutical Co., SL Science Holding, Andros Pharmaceuticals Co., MegaPro Biomedical Co., TTY Biopharm Company, OBI Pharma.

Investor discussion: Handa Pharmaceuticals

Members talk about Handa Pharmaceuticals (6620). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TPEX:6620 on TradingView.

Listing details

Handa Pharmaceuticals Inc is a public biotech or pharmaceutical company listed on TPEX under the ticker 6620, recorded under Taiwan. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Handa Pharmaceuticals Inc
Ticker
6620
Listing
TPEX
Country or territory
Taiwan
Business scope
Pharmaceuticals: Major
ISIN
TW0006620008
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.